Skip to main content
. Author manuscript; available in PMC: 2008 Jun 19.
Published in final edited form as: Exp Neurol. 2006 Dec 20;204(1):485–489. doi: 10.1016/j.expneurol.2006.12.013

Table 1.

Experimental groups.

Group 1 Group 2 Group 3
Day 0 EB injection EB injection EB injection
Days 2–5 BrdU Pulse
Day 7 Nanosphere injection Nanosphere injection Nanosphere injection
Day 9 Sacrifice
Day 14 Sacrifice
Day 35 Sacrifice

Group 1: Animals evaluated for astrogliosis in contralateral VLF following CNTF (n=4) and blank (n=4) nanosphere injection.

Group 2: Animals evaluated for survival of endogenous BrdU-pulsed OPCs following CNTF (n=4) and blank (n=4) nanosphere injection.

Group 3: Animals evaluated for presence of mature oligodendrocytes following CNTF (n=4) and blank (n=4) nanosphere injection into EB lesions.